Werner Frommer
16Patents
7h-index
26Co-inventors
62Inventor score
Filing activity: Feb 28, 1973 → Sep 22, 1986
Most-cited inventions
| Patent | Title | Area | Cited by | Status |
|---|---|---|---|---|
| US4062950A | Amino sugar derivatives | Emerging Cross-Sectional Technologies | 58 | Expired |
| US4391887A | Preparations of micro-organisms | Emerging Cross-Sectional Technologies | 40 | Expired |
| US4634672A | Immobilization of cells in polyurethane hydrogel | Emerging Cross-Sectional Technologies | 20 | Expired |
| US4681851A | Biologically active composition for purifying waste water and outgoing air | Emerging Cross-Sectional Technologies | 16 | Expired |
| US4065557A | Amino sugars and their use in improving the meat:fat ratio in animals | Emerging Cross-Sectional Technologies | 10 | Expired |
| US4019960A | Process for the production of a saccharase inhibitor | Emerging Cross-Sectional Technologies | 8 | Expired |
| US3937817A | Pharmaceutical compositions containing a saccharase inhibitor | Emerging Cross-Sectional Technologies | 8 | Expired |
| US4273571A | Organic chemical compound, microbiological process for its preparation, and its use as a herbicide | Emerging Cross-Sectional Technologies | 5 | Expired |
| US4013510A | Glycoside-hydrolase enzyme inhibitors | Emerging Cross-Sectional Technologies | 4 | Expired |
| US3934006A | Pharmaceutical compositions comprising saccharase inhibitors | Chemistry; Metallurgy | 4 | Expired |
| US4307194A | Inhibitors, obtained from bacilli, for glycoside hydrolases | Emerging Cross-Sectional Technologies | 3 | Expired |
| US4031207A | Antibiotic | Emerging Cross-Sectional Technologies | 1 | Expired |
| US4031208A | Antibiotic | Emerging Cross-Sectional Technologies | 1 | Expired |
| US3951745A | Glycoside-hydrolase enzyme inhibitors | Human Necessities | 1 | Expired |
| US4282320A | Production of 1-desoxynojirimicin | Emerging Cross-Sectional Technologies | 0 | Expired |
| US3995026A | Amylase inhibitor | Emerging Cross-Sectional Technologies | 0 | Expired |
Source: USPTO / EPO open patent data. Inventor disambiguation is heuristic; counts are objective bibliographic measures.